301 related articles for article (PubMed ID: 35408813)
1. Dual Role of YY1 in HPV Life Cycle and Cervical Cancer Development.
Warowicka A; Broniarczyk J; Węglewska M; Kwaśniewski W; Goździcka-Józefiak A
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408813
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic HPV promotes the expression of the long noncoding RNA lnc-FANCI-2 through E7 and YY1.
Liu H; Xu J; Yang Y; Wang X; Wu E; Majerciak V; Zhang T; Steenbergen RDM; Wang HK; Banerjee NS; Li Y; Lu W; Meyers C; Zhu J; Xie X; Chow LT; Zheng ZM
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33436409
[TBL] [Abstract][Full Text] [Related]
3. Protein-DNA Interactions Regulate Human Papillomavirus DNA Replication, Transcription, and Oncogenesis.
Evande R; Rana A; Biswas-Fiss EE; Biswas SB
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239839
[TBL] [Abstract][Full Text] [Related]
4. YY1 is a novel potential therapeutic target for the treatment of HPV infection-induced cervical cancer by arsenic trioxide.
He G; Wang Q; Zhou Y; Wu X; Wang L; Duru N; Kong X; Zhang P; Wan B; Sui L; Guo Q; Li JJ; Yu L
Int J Gynecol Cancer; 2011 Aug; 21(6):1097-104. PubMed ID: 21792014
[TBL] [Abstract][Full Text] [Related]
5. Nuclear proinflammatory cytokine S100A9 enhances expression of human papillomavirus oncogenes via transcription factor TEAD1.
Mori S; Ishii Y; Takeuchi T; Kukimoto I
J Virol; 2023 Aug; 97(8):e0081523. PubMed ID: 37578237
[TBL] [Abstract][Full Text] [Related]
6. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease.
Kennedy EM; Kornepati AV; Goldstein M; Bogerd HP; Poling BC; Whisnant AW; Kastan MB; Cullen BR
J Virol; 2014 Oct; 88(20):11965-72. PubMed ID: 25100830
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of carcinogenesis by human papillomavirus-16.
Ishiji T
J Dermatol; 2000 Feb; 27(2):73-86. PubMed ID: 10721654
[TBL] [Abstract][Full Text] [Related]
9. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic human papillomaviruses activate the tumor-associated lens epithelial-derived growth factor (LEDGF) gene.
Leitz J; Reuschenbach M; Lohrey C; Honegger A; Accardi R; Tommasino M; Llano M; von Knebel Doeberitz M; Hoppe-Seyler K; Hoppe-Seyler F
PLoS Pathog; 2014 Mar; 10(3):e1003957. PubMed ID: 24604027
[TBL] [Abstract][Full Text] [Related]
11. HPV: Molecular pathways and targets.
Gupta S; Kumar P; Das BC
Curr Probl Cancer; 2018; 42(2):161-174. PubMed ID: 29706467
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus E7 binds Oct4 and regulates its activity in HPV-associated cervical cancers.
Panayiotou T; Michael S; Zaravinos A; Demirag E; Achilleos C; Strati K
PLoS Pathog; 2020 Apr; 16(4):e1008468. PubMed ID: 32298395
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers.
Dong XP; Stubenrauch F; Beyer-Finkler E; Pfister H
Int J Cancer; 1994 Sep; 58(6):803-8. PubMed ID: 7927871
[TBL] [Abstract][Full Text] [Related]
14. Proteasomal degradation of p130 facilitate cell cycle deregulation and impairment of cellular differentiation in high-risk Human Papillomavirus 16 and 18 E7 transfected cells.
Gandhi S; Nor Rashid N; Mohamad Razif MF; Othman S
Mol Biol Rep; 2021 Jun; 48(6):5121-5133. PubMed ID: 34169395
[TBL] [Abstract][Full Text] [Related]
15. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
16. Disruption of CTCF-YY1-dependent looping of the human papillomavirus genome activates differentiation-induced viral oncogene transcription.
Pentland I; Campos-León K; Cotic M; Davies KJ; Wood CD; Groves IJ; Burley M; Coleman N; Stockton JD; Noyvert B; Beggs AD; West MJ; Roberts S; Parish JL
PLoS Biol; 2018 Oct; 16(10):e2005752. PubMed ID: 30359362
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms underlying human papillomavirus E6 and E7 oncoprotein-induced cell transformation.
Mittal S; Banks L
Mutat Res Rev Mutat Res; 2017; 772():23-35. PubMed ID: 28528687
[TBL] [Abstract][Full Text] [Related]
18. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.
Yew CW; Lee P; Chan WK; Lim VK; Tay SK; Tan TM; Deng LW
Cancer Res; 2011 Nov; 71(21):6696-707. PubMed ID: 21908553
[TBL] [Abstract][Full Text] [Related]
19. [Molecular basis of cervical carcinogenesis by high-risk human papillomaviruses].
Yugawa T; Kiyono T
Uirusu; 2008 Dec; 58(2):141-54. PubMed ID: 19374192
[TBL] [Abstract][Full Text] [Related]
20. Yin yang 1 negatively regulates the differentiation-specific E1 promoter of human papillomavirus type 6.
Ai W; Narahari J; Roman A
J Virol; 2000 Jun; 74(11):5198-205. PubMed ID: 10799595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
